[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

YU43170B - Process for obtaining crystalline benzo-sulphonate salts of sultamicillin - Google Patents

Process for obtaining crystalline benzo-sulphonate salts of sultamicillin

Info

Publication number
YU43170B
YU43170B YU904/83A YU90483A YU43170B YU 43170 B YU43170 B YU 43170B YU 904/83 A YU904/83 A YU 904/83A YU 90483 A YU90483 A YU 90483A YU 43170 B YU43170 B YU 43170B
Authority
YU
Yugoslavia
Prior art keywords
sultamicillin
benzo
obtaining crystalline
sulphonate salts
sulphonate
Prior art date
Application number
YU904/83A
Other languages
English (en)
Other versions
YU90483A (en
Inventor
W E Barth
V J Jasys
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU90483A publication Critical patent/YU90483A/xx
Publication of YU43170B publication Critical patent/YU43170B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
YU904/83A 1982-04-23 1983-04-21 Process for obtaining crystalline benzo-sulphonate salts of sultamicillin YU43170B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/371,156 US4432987A (en) 1982-04-23 1982-04-23 Crystalline benzenesulfonate salts of sultamicillin

Publications (2)

Publication Number Publication Date
YU90483A YU90483A (en) 1986-04-30
YU43170B true YU43170B (en) 1989-04-30

Family

ID=23462725

Family Applications (1)

Application Number Title Priority Date Filing Date
YU904/83A YU43170B (en) 1982-04-23 1983-04-21 Process for obtaining crystalline benzo-sulphonate salts of sultamicillin

Country Status (27)

Country Link
US (1) US4432987A (fr)
EP (1) EP0092968B1 (fr)
JP (1) JPS58201792A (fr)
KR (1) KR860001279B1 (fr)
AU (1) AU536854B2 (fr)
CA (1) CA1187484A (fr)
CS (1) CS235320B2 (fr)
DD (1) DD209632A5 (fr)
DE (1) DE3362502D1 (fr)
DK (1) DK162168C (fr)
EG (1) EG16412A (fr)
ES (1) ES521728A0 (fr)
FI (1) FI76092C (fr)
GR (1) GR78582B (fr)
HK (1) HK20588A (fr)
HU (1) HU187068B (fr)
IE (1) IE54628B1 (fr)
IL (1) IL68453A (fr)
NO (1) NO156202C (fr)
NZ (1) NZ203988A (fr)
PH (1) PH18035A (fr)
PL (1) PL134978B1 (fr)
PT (1) PT76587B (fr)
SG (1) SG104087G (fr)
SU (1) SU1138030A3 (fr)
YU (1) YU43170B (fr)
ZA (1) ZA832845B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3688613T2 (de) * 1985-11-18 1994-01-13 Access Pharma Inc Polychelierende stoffe für abbildung- und spektralerhöhung (und spektrale verschiebung).
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
AU700545B2 (en) * 1994-05-02 1999-01-07 Shionogi & Co., Ltd. Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
KR100582141B1 (ko) 2002-08-29 2006-05-22 다이쇼 세이야꾸 가부시끼가이샤 4-플루오로-2-시아노피롤리딘 유도체 벤젠술폰산염
DE602004022643D1 (de) * 2003-03-27 2009-10-01 Basilea Pharmaceutica Ag Cephalosporin in kristalliner form
JP2007509976A (ja) * 2003-10-31 2007-04-19 アルザ・コーポレーシヨン 増加された鉄の吸収のための組成物及び投与形態
FR2877696B1 (fr) 2004-11-09 2009-09-18 Renault Sas Dispositif et procede d'estimation en temps reel de l'angle de debut de combustion d'un moteur a combustion interne
WO2009024823A2 (fr) 2007-08-22 2009-02-26 Astrazeneca Ab Dérivés de cyclopropyl amide 978
WO2009055053A2 (fr) 2007-10-26 2009-04-30 The Regents Of The University Of California Composés de diarylhydantoïne
AU2010208265B2 (en) * 2009-01-30 2012-12-06 Novartis Ag Crystalline N-{(1 S)-2-amino-1-[(3- fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1 H-pyrazol-5-yl)-2- thiophenecarboxamide hydrochloride
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
CA2767785A1 (fr) * 2009-07-10 2011-01-13 Evolva Ag Compositions de diynes
AR080203A1 (es) * 2010-02-18 2012-03-21 Astrazeneca Ab Formas solidas que comprenden una ciclopropilamida
US9012452B2 (en) * 2010-02-18 2015-04-21 Astrazeneca Ab Processes for making cyclopropyl amide derivatives and intermediates associated therewith
CN104903289B (zh) * 2012-12-03 2017-06-09 株式会社钟化 还元型辅酶q10衍生物及其制造方法
KR20230159631A (ko) * 2013-09-05 2023-11-21 미쓰비시 타나베 파마 코퍼레이션 신규한 결정성 아릴알킬아민 화합물 및 그의 제조 방법
MX2017005120A (es) * 2014-10-21 2018-02-12 Ariad Pharma Inc Formas cristalinas de 5-cloro-n4-[-2-(dimetilfosforil) fenil]-n2-{2-metoxi-4-[4-(4-metilpiperazin-1-il)piperidin-1-il] pirimidin-2,4-diamina.
CN104958318A (zh) * 2015-08-04 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗感染性疾病的药物舒巴坦钠组合物
CA3011323A1 (fr) * 2016-01-22 2017-07-27 Sandoz Ag Bis-chlorhydrate d'eravacycline cristalline
IL263996B2 (en) * 2016-07-07 2024-03-01 Ironwood Pharmaceuticals Inc Solid configurations of the SGC promoter
WO2019089540A1 (fr) * 2017-10-30 2019-05-09 Theracaine Llc Sels d'arènesulfonate hydrophobes
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
UA119735C2 (uk) 2018-12-20 2019-07-25 Анатолій Семенович Редер Фармацевтична сполука, спосіб її отримання та застосування як лікарського засобу
USD1049292S1 (en) * 2021-04-06 2024-10-29 Springfield, Inc. Pistol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
BE881675A (fr) * 1979-02-13 1980-08-12 Leo Pharm Prod Ltd B-lactames derives de l'acide penicillanique leur preparation et leurs utilisations therapeutiques
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
GB2084572B (en) * 1980-10-06 1984-07-11 Leo Pharm Prod Ltd 1,1-dioxopenicillanoyloxymethyl 6-(d-aphenylacetamido)penicillanate napsylate
IL64009A (en) * 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
US4432987A (en) 1984-02-21
IL68453A0 (en) 1983-07-31
EP0092968B1 (fr) 1986-03-12
ES8406075A1 (es) 1984-07-01
IE830926L (en) 1983-10-23
PH18035A (en) 1985-03-06
EG16412A (en) 1989-03-30
ES521728A0 (es) 1984-07-01
EP0092968A1 (fr) 1983-11-02
NO156202C (no) 1987-08-19
FI76092B (fi) 1988-05-31
SG104087G (en) 1988-07-15
CS235320B2 (en) 1985-05-15
YU90483A (en) 1986-04-30
DK101783A (da) 1983-10-24
NO156202B (no) 1987-05-04
DK162168B (da) 1991-09-23
SU1138030A3 (ru) 1985-01-30
HU187068B (en) 1985-11-28
AU1387183A (en) 1983-11-17
FI76092C (fi) 1988-09-09
AU536854B2 (en) 1984-05-24
CA1187484A (fr) 1985-05-21
JPS58201792A (ja) 1983-11-24
KR840004437A (ko) 1984-10-15
FI831392A0 (fi) 1983-04-22
FI831392L (fi) 1983-10-24
NO831430L (no) 1983-10-24
NZ203988A (en) 1986-01-24
PL134978B1 (en) 1985-09-30
KR860001279B1 (ko) 1986-09-05
DK162168C (da) 1992-03-02
DE3362502D1 (en) 1986-04-17
IL68453A (en) 1986-08-31
HK20588A (en) 1988-03-25
PL241553A1 (en) 1983-11-21
PT76587B (en) 1986-02-27
DD209632A5 (de) 1984-05-16
PT76587A (en) 1983-05-01
JPH0119395B2 (fr) 1989-04-11
GR78582B (fr) 1984-09-27
ZA832845B (en) 1984-11-28
IE54628B1 (en) 1989-12-20
DK101783D0 (da) 1983-02-28

Similar Documents

Publication Publication Date Title
YU43170B (en) Process for obtaining crystalline benzo-sulphonate salts of sultamicillin
YU44680B (en) Process for obtaining very pure amorphous form of cephuroxim axetile
YU43545B (en) Process for obtaining n-imidazolylderivatives of bicyclical compounds
YU42767B (en) Process for obtaining crystalline salts of benzothiazin-dioxide
DE3374305D1 (en) Process for the preparation of quaternary ammonium salts
IL70544A (en) Crystalline cephem-acid addition salts and process for their preparation
PL238024A1 (en) Process for preparing stable salts of s-adenosilmethionine
DE3467577D1 (en) Process for the preparation of n-glycidyl compounds
PL243949A1 (en) Process for preparing derivatives of phenyl-cyclobutylamine
YU118880A (en) Process for obtaining salts of thiazolylidene-oxo-propionitrile
PL244495A1 (en) Process for preparing salts of n-phosphonomethylglycin
YU42855B (en) Process for making derivatives of carbazine acid
PT80999A (en) Process for the preparation of cyclimmonium salts
YU224786A (en) Process for obtaining of indolylalkyl-aminopropanole
DE3462139D1 (en) Process for the preparation of hydroxybenzylphosphonium salts
YU44123B (en) Process for making crystalline natrium cephoperazone
KE3785A (en) Crystalline benzenesulfonate salts of sultamicillin
PL241020A1 (en) Process for preparing derivatives of pterocarpane
AU553252B2 (en) Crystalline salts of cefodizim
YU158584A (en) Process for making salts of antimalaric phenanthrenemethanol compounds
HUT37425A (en) Process for preparing crystalline benzothiazine-dioxide salts
PT78548A (en) Process for the preparation bis-alkylphosphonium salts of n-phosphonomethylglycine
PL237537A1 (en) Method of manufacture of crystalline microcellulose
BG33350A1 (en) Method for obtaining of ethelene- bis- dithoicarbamide acid- diammonium salt
PL132717B2 (en) Process for preparation of alpha-amino-epsilon-caprolactam